{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:22:28Z","timestamp":1794853348053,"version":"4.9.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Melanoma, a highly aggressive malignancy characterized by rapid metastasis and elevated mortality rates, predominantly originates in cutaneous tissues. While surgical interventions, immunotherapy, and targeted therapies have advanced, the prognosis for advanced-stage melanoma remains dismal. Globally, melanoma incidence continues to rise, with the United States alone reporting over 100,000 new cases and 7,000 deaths annually. Despite the exponential growth of tumor data facilitated by next-generation sequencing (NGS), current analytical approaches predominantly emphasize single-gene analyses, neglecting critical insights into complex gene interaction networks. This study aims to address this gap by systematically exploring immune gene regulatory dynamics in melanoma progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We developed a bidirectional, weighted, signed, and directed topological immune gene regulatory network to compare transcriptional landscapes between benign melanocytic nevi and cutaneous melanoma. Advanced network analysis tools were employed to identify structural disparities and functional module shifts. Key driver genes were validated through topological centrality metrics. Additionally, deep learning models were implemented to predict drug-target interactions, leveraging molecular features derived from network analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Significant topological divergences emerged between nevi and melanoma networks, with dominant functional modules transitioning from cell cycle regulation in benign lesions to DNA repair and cell migration pathways in malignant tumors. A group of genes, including AURKA, CCNE1, APEX2, and EXOC8, were identified as potential orchestrators of immune microenvironment remodeling during malignant transformation. The deep learning framework successfully predicted 23 clinically actionable drug candidates targeting these molecular drivers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The observed module shift from cell cycle to invasion-related pathways provides mechanistic insights into melanoma progression, suggesting early therapeutic targeting of DNA repair machinery might mitigate metastatic potential. The identified hub genes, particularly AURKA and DDX19B, represent novel candidates for immunomodulatory interventions. Our computational drug prediction strategy bridges molecular network analysis with clinical translation, offering a paradigm for precision oncology in melanoma. Future studies should validate these targets in preclinical models and explore network-based biomarkers for early detection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2025.1471037","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:05:50Z","timestamp":1740985550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of biomarkers and target drugs for melanoma: a topological and deep learning approach"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiwei","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jipeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20190417","DOI":"10.1098\/rsif.2019.0417","article-title":"Gestational growth trajectories derived from a dynamic fetal-placental scaling law","volume":"16","author":"Baller","year":"2019","journal-title":"J. R. Soc. Interface"},{"key":"B2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41586-024-07563-1","article-title":"Multiscale topology classifies cells in subcellular spatial transcriptomics","volume":"630","author":"Benjamin","year":"2024","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1542\/peds.106.4.736","article-title":"Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis","volume":"106","author":"Bittencourt","year":"2000","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"D1228","DOI":"10.1093\/nar\/gks1147","article-title":"InnateDB: systems biology of innate immunity and beyond\u2013recent updates and continuing curation","volume":"41","author":"Breuer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jaad.2022.04.056","article-title":"Melanoma in skin of color: Part I. epidemiology and clinical presentation","volume":"89","author":"Brunsgaard","year":"2023","journal-title":"J. Am. Acad. Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41540-019-0116-1","article-title":"An omnidirectional visualization model of personalized gene regulatory networks","volume":"5","author":"Chen","year":"2019","journal-title":"NPJ Syst. Biol. Appl."},{"key":"B7","doi-asserted-by":"publisher","first-page":"vi51","DOI":"10.1093\/annonc\/mdp255","article-title":"A systematic review of health-related quality of life in cutaneous melanoma","volume":"20","author":"Cornish","year":"2009","journal-title":"Ann. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41592-021-01153-z","article-title":"Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing","volume":"18","author":"Datlinger","year":"2021","journal-title":"Nat. Methods"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/2041-210x.14172","article-title":"idopNetwork: a network tool to dissect spatial community ecology","volume":"14","author":"Dong","year":"2023","journal-title":"Methods Ecol. Evol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/biom13101516","article-title":"Using LLMs and explainable ML to analyze biomarkers at single-cell level for improved understanding of diseases","volume":"13","author":"Elsborg","year":"2023","journal-title":"Biomolecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-19-2268","article-title":"Topological tumor graphs: a graph-based spatial model to infer stromal recruitment for immunosuppression in melanoma histology","volume":"80","author":"Failmezger","year":"2020","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-09-3151","article-title":"Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome","volume":"16","author":"Grunda","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkab629","article-title":"TSMiner: a novel framework for generating time-specific gene regulatory networks from time-series expression profiles","volume":"49","author":"Han","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.1093\/nar\/gkac689","article-title":"Metagenomics versus total RNA sequencing: most accurate data-processing tools, microbial identification accuracy and perspectives for ecological assessments","volume":"50","author":"Hempel","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1093\/bioinformatics\/btaa1005","article-title":"DeepPurpose: a deep learning library for drug-target interaction prediction","volume":"36","author":"Huang","year":"2021","journal-title":"Bioinformatics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2324977","DOI":"10.1001\/jamanetworkopen.2023.24977","article-title":"Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors","volume":"6","author":"Jentzsch","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.1158\/1078-0432.CCR-08-1144","article-title":"Imatinib targeting of KIT-mutant oncoprotein in melanoma","volume":"14","author":"Jiang","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41568-022-00442-9","article-title":"Mechanisms of immune activation and regulation: lessons from melanoma","volume":"22","author":"Kalaora","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1534\/genetics.108.093690","article-title":"A computational approach to the functional clustering of periodic gene-expression profiles","volume":"180","author":"Kim","year":"2008","journal-title":"Genetics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1038\/s41388-018-0385-y","article-title":"RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas","volume":"37","author":"Kunz","year":"2018","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1098\/rspb.2009.1409","article-title":"Network cohesion, group size and neocortex size in female-bonded Old World primates","volume":"276","author":"Lehmann","year":"2009","journal-title":"Proc. Biol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.1253735","article-title":"The melanoma revolution: from UV carcinogenesis to a new era in therapeutics","volume":"346","author":"Lo","year":"2014","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.3390\/ijms25179345","article-title":"A combined proteomic and transcriptomic signature is predictive of response to anti-PD-1 treatment: a retrospective study in metastatic melanoma patients","volume":"25","author":"Mallardo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12967-022-03643-w","article-title":"Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization","volume":"20","author":"Mallardo","year":"","journal-title":"J. Transl. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1186\/s12967-023-04607-4","article-title":"The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab","volume":"21","author":"Mallardo","year":"2023","journal-title":"J. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e005132","DOI":"10.1136\/jitc-2022-005132","article-title":"Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis","volume":"10","author":"Mallardo","year":"","journal-title":"J. Immunother. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jaad.2022.05.062","article-title":"Central nervous system magnetic resonance imaging abnormalities and neurologic outcomes in pediatric patients with congenital nevi: a 10-year multi-institutional retrospective study","volume":"87","author":"Neale","year":"2022","journal-title":"J. Am. Acad. Dermatol"},{"key":"B30","unstructured":"Cancer stat facts: melanoma of the skin\n          \n          \n          2024"},{"key":"B31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013adjuvant or adjuvant-only pembrolizumab in advanced melanoma","volume":"388","author":"Patel","year":"","journal-title":"New England J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamadermatol.2023.1494","article-title":"Risk of mortality after a diagnosis of melanoma in situ","volume":"159","author":"Patel","year":"","journal-title":"JAMA Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/bjc.2013.477","article-title":"Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma","volume":"109","author":"Plummer","year":"2013","journal-title":"Br. J. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1476-4598-12-159","article-title":"The roles of FOXM1 in pancreatic stem cells and carcinogenesis","volume":"12","author":"Quan","year":"2013","journal-title":"Mol. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jaad.2018.06.007","article-title":"Health-related quality of life in patients with malignant melanoma by stage and treatment status","volume":"85","author":"Rosenberg","year":"2021","journal-title":"J. Am. Acad. Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101721","DOI":"10.1016\/j.arr.2022.101721","article-title":"An integrative machine-learning meta-analysis of high-throughput omics data identifies age-specific hallmarks of Alzheimer\u2019s disease","volume":"81","author":"Shokhirev","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.semcancer.2019.08.024","article-title":"The adjuvant treatment revolution for high-risk melanoma patients","volume":"59","author":"Spagnolo","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1200\/JCO.18.00925","article-title":"Cyclin E1 expression and palbociclib efficacy in previously treated hormone receptor-positive metastatic breast cancer","volume":"37","author":"Turner","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1158\/0008-5472.CAN-14-2405","article-title":"Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells","volume":"75","author":"Vilgelm","year":"2015","journal-title":"Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41586-023-06221-2","article-title":"Scientific discovery in the age of artificial intelligence","volume":"620","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses","volume":"384","author":"Welch","year":"2021","journal-title":"New England J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e2308496120","DOI":"10.1073\/pnas.2308496120","article-title":"The metabolomic physics of complex diseases","volume":"120","author":"Wu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","article-title":"Emerging roles of Aurora-A kinase in cancer therapy resistance","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"B46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41477-020-00815-8","article-title":"Dynamic allometric scaling of tree biomass and size","volume":"7","author":"Zhou","year":"2021","journal-title":"Nat. Plants"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1471037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:05:55Z","timestamp":1740985555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1471037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":47,"alternative-id":["10.3389\/fgene.2025.1471037"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1471037","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fgene.2025.1471037.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fgene.2025.1471037.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fgene.2025.1471037.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fgene.2025.1471037.s004","asserted-by":"subject"}]},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"article-number":"1471037"}}